Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Ryan Cohens latest substantial open-market share purchase is driving attention, with many traders viewing the repeated insider buying as a bullish signal and speculating about a short squeeze. Others question whether the buying is tied to the warrant program and possible dilution, or whether it can sustain a move higher.

Bank of Americas anti-money-laundering and sanctions failures drew attention after regulators imposed a major penalty ahead of its quarterly earnings report. Traders largely criticized the bank and discussed downside risk, while others argued the financial hit was manageable or that the issues had already been addressed.

JPMorgans quarterly earnings miss, tied largely to weaker fixed-income trading and a securities loss, is driving discussion; stronger net interest income helped offset the shortfall. Traders are divided over the stocks resilience and volatile reaction, weighing the miss against the banks lending performance and outlook.

Strives expiring warrants and their exercise are driving discussion, with traders debating whether added share supply will weigh on the stock or whether proceeds used to buy Bitcoin can support its treasury strategy. Recent filings report warrant exercises alongside additional Bitcoin purchases, while concerns about dilution remain prominent.

Fubos low-volume selloff and approach toward recent lows dominate the conversation, with traders debating whether the weakness reflects technical selling or deeper business concerns. Bulls are looking to the new CEOs strategic plan and upcoming earnings for evidence of progress, while bears focus on dilution risk and the companys competitive position; hopes for Disney integration remain speculative.

Take-Two is drawing attention around the anticipated launch of Grand Theft Auto VI and its potential sales and long-term online revenue. Traders are split between expecting strong demand to lift the stock and worrying that launch hype is already priced in, while weak price action and uncertainty around online plans and leak threats fuel frustration.

Liquidia and United Therapeutics reached a global settlement resolving their pending litigation, with YUTREPIA remaining available for PAH patients. Traders largely welcome the certainty and continued commercialization, while debating the settlements financial burden and the stocks prospects.

Citigroups quarterly results beat expectations, but shares fell despite the strong report as traders focused on higher credit-loss provisions and card-credit risks; some investors viewed the pullback as a buying opportunity. The move also came amid weakness across financial stocks.

UnitedHealths quarterly earnings beat and raised outlook, supported by improved medical-cost control, are the main catalyst. Traders are divided as the shares gave back early gains: some see the report as evidence of a turnaround, while others question the muted price reaction and focus on cost pressures.

Applied Materials Investor Day selloff is tied to management offering no concrete near-term wafer-fab equipment spending forecast, citing uncertainties including cleanroom capacity, supply chains and energy infrastructure. Traders are split: some see the long-term AI-driven growth targets as intact and the drop as an overreaction, while others worry the lack of near-term visibility leaves expectations too high.